Skip to content
Home/Companies/Biotech/GQ Bio Therapeutics
GB

GQ Bio Therapeutics

Biotech·Germany·Exited 2025·Held 13yr

GQ Bio Therapeutics is a biotech company, headquartered in Germany.

Entry
2012
Hold
13yr
Exit
2025
Est. EV
–

Who owns GQ Bio Therapeutics?

GQ Bio Therapeutics was owned by IFB Innovationsstarter through Innovationsstarter Fonds Hamburg I (2012 vintage) from 2012 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

IFB Innovationsstarter
Investor
IFB Innovationsstarter
Innovationsstarter Fonds Hamburg I · 2012 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from Innovationsstarter Fonds Hamburg I

Other portfolio companies in the same fund.

bentekk
Exited 2017
IndustrialsGermany· 2016
to
Protembis
Active
MedTechGermany· 2015
i3 Membrane
Active
MedTechGermany· 2014
CustomCells
Exited 2025
EnergyGermany· 2013

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings